DAWN R&D to Revenue
Day One Biopharmaceuticals Inc · R&D to Revenue
DAWN R&D to Revenue
Latest reported76.23%period ending
DAWN Quarterly R&D/Revenue (0.00% → 76.23%)
Latest values, visible window
High-resolution chart · PNG
DAWN r&d to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 76.2277% | |
| 78.9521% | |
| 106.6091% | |
| 128.7962% | |
| 211.6646% | |
| 35.7963% | |
| 1,124.3408% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |